RZarychanski Profile Banner
Ryan Zarychanski Profile
Ryan Zarychanski

@RZarychanski

Followers
786
Following
251
Media
9
Statuses
375

Professor, Hematology/Critical Care. Clinician-Scientist studying hematologic consequences of critical illness.

Winnipeg, Manitoba, Canada
Joined April 2015
Don't wanna be here? Send us removal request.
@RZarychanski
Ryan Zarychanski
2 years
Congratulations Deborah & team. This trial needed be done for years and you figured out how to get it done in a way that compels us all to change practice. Use smaller tubes; take less blood; reduce transfusion, especially at a strained system level. Amazing!
@DebSiegal
Deborah Siegal
2 years
STRATUS Trial published @JAMA_current 🩸Cluster trial 25 ICUs >27,000 patients 🩸Switch to “small-volume” tubes that⬇️blood drawn for lab tests may⬇️RBC transfusion↔️effect on testing 🩸Available, cost-neutral, compatible with analyzers – will you switch? https://t.co/sTkJVyfrgS
0
4
26
@RZarychanski
Ryan Zarychanski
2 years
Inspiring Lyonel G Israels Memorial lecture and special session on women leaders in medicine by Dr. Saskia Middeldorp - she won the heart of every Winnipeg’er who attended. What an enormous impact in such a short amount of time. Thank you Saskia!
@MiddeldorpS
Saskia Middeldorp
2 years
What an amazing experience to address the Lyonel G. Israels Memorial Lecture today @CCMB_Research. Thanks @RZarychanski and team for hosting me!
0
0
10
@RZarychanski
Ryan Zarychanski
2 years
Spectacular field trip hiking the Hunt Lake trail with @MiddeldorpS and Winnipeg colleagues - work hard; play hard, while making memories and friendships together. What a day!!!
@MiddeldorpS
Saskia Middeldorp
2 years
#Winnipeg hematology field trip - day 2 of visiting professorship was sooo exciting and fun! Thanks ⁦@RZarychanski⁩ and hematologists for a great experience at the center of 🇨🇦🙏🏼
0
0
7
@RZarychanski
Ryan Zarychanski
2 years
Congratulations Saskia, Mariette, Siobhan and team!
@MiddeldorpS
Saskia Middeldorp
2 years
Leaving #ISTH2023? Just a tip for your read on the way home about @ALIFE2trial #ALIFE2 @TheLancet link to the full paper - for free download until July 21st! #heparin #LMWH #pregnancy #recurrent # miscarriage
0
1
3
@RZarychanski
Ryan Zarychanski
2 years
Excited & privileged to receive funding from @Research_MB to create skilled jobs, build clinical trial expertise in Manitoba, and provide mentoring opportunities for new researchers - all while improving outcomes for patients with pneumonia! @CancerCareMB @UM_RadyFHS
@Research_MB
Research Manitoba
2 years
We are pleased to announce an investment of $500K allocated over 5 years designated to support the ATTACC-CAP trail led by @umanitoba researcher @RZarychanski, this will be the second-largest clinical trial led out of Manitoba. Read full news release: https://t.co/LsO2soXVIq
6
3
29
@RZarychanski
Ryan Zarychanski
2 years
Do not miss! - Only 2 more days to @MiddeldorpS. Join virtually or in person. @isth #ISTH2023 @INVENT_VTE @EHA_Hematology @ASH_hematology Find out the latest data! Hear about patience, persistence, collaboration, and passion to improve thrombotic maternal-fetal outcomes.
@MiddeldorpS
Saskia Middeldorp
2 years
Looking forward! The day after #ISTH2023 👇🏼
1
3
4
@RZarychanski
Ryan Zarychanski
2 years
Calling all those who dare to be inspired! Only 2 more days. Join virtually or in person. ALL are welcome. https://t.co/Bjxz5QE0sP @MiddeldorpS @UM_RadyFHS @CMA_Docs @DoctorsManitoba @UHN @mcgillu @uOttawa @CPHO_Canada
0
8
13
@CalltoActivism
CALL TO ACTIVISM
2 years
There was a little coffee shop where two people arrived and approached the counter. “Five coffees ☕️ please. Two for us and three pending.” They paid, they took their two coffees and left. I asked the waiter. "What’s this about pending coffees?" “Wait and you'll see." Some
542
6K
29K
@RZarychanski
Ryan Zarychanski
2 years
UM’s College of Pharmacy student is doing a superb job presenting the impact of symptom duration prior to hospitalization on clinical outcomes in Covid and whether symptom duration impacts the treatment effect of therapeutic-dose heparin. Well done Quinn! @ISTH @UM_RadyFHS
0
2
10
@macky_neal
Matthew D. Neal, MD
2 years
Brilliant talk by my friend @RZarychanski on the role of adaptive clinical trials and assessing heterogeneity of treatment effect on #immunothrombosis #ISTH2023 @isth
1
2
24
@RZarychanski
Ryan Zarychanski
2 years
Thank you! Just as medical treatments have evolved, so have randomized trials. The next generation of trials will need to designed to detect and quantify heterogenous treatment effects (HTE) so that we can identify patients who benefit or may be harmed. Enough negative trials -
@fernandahemato
Fernanda Santos
2 years
Great presentation! We have so much to improve in our clinical practice in immunothrombosis.
1
3
17
@fernandahemato
Fernanda Santos
2 years
Great presentation! We have so much to improve in our clinical practice in immunothrombosis.
1
3
6
@RZarychanski
Ryan Zarychanski
2 years
It’s time to design and conduct trials differently than we have in the past so we can detect heterogenous treatment effects and identify patients who will benefit or be harmed! @remap_cap @UM_RadyFHS @CancerCareMB @ATTACC_COVID
@MarcCarrier1
Marc Carrier
2 years
Brillant presentation by Dr. @RZarychanski on identification of patients that will benefit from heparin/LMWH as an Immunothrombosis-directed agent @ThrombosisCan @canvector #ISTH2023
0
3
18
@RZarychanski
Ryan Zarychanski
2 years
Wonderful presentation by Manitoba’s own Quinn Tays at the International Society on Thrombosis and Haemoatasis Congress in Montreal - if therapeutic heparin is started for Covid on the ward, reduce the dose to prophylaxis if the patient requires ICU-level care
@ThrombosisCan
Thrombosis Canada
2 years
Quinn Tays from @umanitoba presents on Impact of heparin on disease state transition in hospitalized, non-critically ill patients with COVID-19; secondary analysis of an international multi-platform RCT at 13:30 in room 511 @Rzarychanski @MarcCarrier1 @LanaCastellucci #ISTH2023
0
0
1
@CancerCareMB
CancerCare Manitoba
2 years
We hope you'll join us! Hear from Dr. @MiddeldorpS on "Women in High Places." Register by June 21 https://t.co/FecDpI05Ro #Winnipeg #CareerSuccess
0
3
6
@RZarychanski
Ryan Zarychanski
2 years
A Special Session with Dr. Saskia Middeldorp not to miss! -- Leading & succeeding from a female perspective. Join us in person, or virtually, from wherever you are. All our welcome @MiddeldorpS @isth @canvector @INVENT_VTE @UM_RadyFHS @SOGCorg @ASH_hematology @CCMB_Research
@CancerCareMB
CancerCare Manitoba
2 years
Join us on June 29 for a thought-provoking lecture by Dr. @MiddeldorpS on "Women in High Places." Gain valuable insight on strategizing for career success while balancing work, family & life. Don't miss this empowering session! RSVP by June 21 https://t.co/FecDpI05Ro
0
3
6
@RZarychanski
Ryan Zarychanski
2 years
All are welcome! Incredible privilege to have Dr. Middeldorp in Winnipeg, Canada to deliver the Lyonel G Israels Memorial Lecture. Please join us in person, or virtually, from wherever you are. @MiddeldorpS @isth @canvector @INVENT_VTE @UM_RadyFHS @SOGCorg @ASH_hematology
@CancerCareMB
CancerCare Manitoba
2 years
➡️Attention all! Join us for the 18th Annual Lyonel G. Israels Memorial Lecture with Dr. Saskia Middeldorp on "Thrombosis, Thrombophilia, & Pregnancy" on June 29 at noon - in person or online! Register by June 22 at https://t.co/IJD7QYRX82 #Thrombosis #Thrombophilia #Pregnancy
1
8
18
@VPrasadMDMPH
Vinay Prasad MD MPH
2 years
Disgusting, unethical PLACEBO control trial in colon cancer just so Fruquitinib can win I will show you that placebo should not have been the control arm, & the IRBs & FDA failed 🧵 First, this trial tests a new drug vs. placebo (sugar pill) in patients dying of colon cancer
32
120
648